STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

CURANEX PHARMACEUTICALS Stock Price, News & Analysis

CURX NASDAQ

Company Description

Welcome to the overview page for CURANEX PHARMACEUTICALS (CURX), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$0.4600
+5.75%
+0.03
Last updated: December 8, 2025 at 06:25
-89.18 %
Performance 1 year
$12.6M

Financial Highlights

$954,059
Net Income (TTM)
$9,627,048
Operating Cash Flow
Revenue (TTM)

Upcoming Events

JAN
01
January 1, 2026 Regulatory

IND submission

Submission of IND for lead Ulcerative Colitis candidate to FDA

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of CURANEX PHARMACEUTICALS (CURX)?

The current stock price of CURANEX PHARMACEUTICALS (CURX) is $0.435 as of December 5, 2025.

What is the market cap of CURANEX PHARMACEUTICALS (CURX)?

The market cap of CURANEX PHARMACEUTICALS (CURX) is approximately 12.6M. Learn more about what market capitalization means .

What is the net income of CURANEX PHARMACEUTICALS (CURX)?

The trailing twelve months (TTM) net income of CURANEX PHARMACEUTICALS (CURX) is $954,059.

What is the earnings per share (EPS) of CURANEX PHARMACEUTICALS (CURX)?

The diluted earnings per share (EPS) of CURANEX PHARMACEUTICALS (CURX) is $0.04 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of CURANEX PHARMACEUTICALS (CURX)?

The operating cash flow of CURANEX PHARMACEUTICALS (CURX) is $9,627,048. Learn about cash flow.

What is the current ratio of CURANEX PHARMACEUTICALS (CURX)?

The current ratio of CURANEX PHARMACEUTICALS (CURX) is 77.53, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of CURANEX PHARMACEUTICALS (CURX)?

The operating income of CURANEX PHARMACEUTICALS (CURX) is $951,327. Learn about operating income.